{"id":"W3004551912","doi":"10.1200/jco.2020.38.4_suppl.tps268","title":"AGENT: An open-label phase III study of arfolitixorin versus leucovorin in modified FOLFOX-6 for first-line treatment of metastatic colorectal cancer.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; FOLFOX; Oxaliplatin; Bevacizumab; Internal medicine; Tolerability; Clinical endpoint; Colorectal cancer; Oncology; Irinotecan; Phases of clinical research; Cetuximab; Thymidylate synthase; Progression-free survival; Fluorouracil; Clinical trial; Cancer; Chemotherapy; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001945282,0.002127481,0.002665872,0.0005943533,0.0005110441,0.00114601,0.001566886,0.001998232,0.0114331],"category_scores_gemma":[0.001594435,0.0008774026,0.001833445,0.0004543577,0.001196631,0.001258043,0.0003751389,0.004067784,0.002504561],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001176175,"about_ca_system_score_gemma":0.002004562,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001185359,"about_ca_topic_score_gemma":0.003079646,"domain_scores_codex":[0.9995117,0.0002409198,0.00002477846,0.00007646394,0.00005045944,0.00009574679],"domain_scores_gemma":[0.9990816,0.0001598397,0.000179991,0.00007529619,0.00007067792,0.0004326778],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9286824,0.03518512,0.0007668097,0.0005845641,0.000621603,0.00009074531,0.00009660138,0.0005705467,0.007943618,0.0002160097,0.002250242,0.02299176],"study_design_scores_gemma":[0.8512819,0.145272,0.00118523,0.00002076457,0.0001764036,0.0000600675,0.00001970312,0.0004213025,0.0004972285,0.00009602943,0.0009566622,0.00001271836],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9745958,0.002953153,0.001259398,0.001131359,0.0006668039,0.01176176,0.003827174,0.0003618193,0.00344281],"genre_scores_gemma":[0.9651875,0.003082638,0.00393148,0.001941725,0.0007016793,0.01225485,0.004492013,0.00009848352,0.008309643],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0114331,"threshold_uncertainty_score":0.03824753,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.5170207306562354,"score_gpt":0.5729376464985312,"score_spread":0.05591691584229574,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}